Shandong Sinobioway Biomedicine Co Ltd (002581) — Cash Flow-to-Debt Ratio
Shandong Sinobioway Biomedicine Co Ltd (002581) has a Cash Flow-to-Debt Ratio of -0.39x as of September 2025, meaning its operating cash flow of CN¥-86.58 Million could theoretically repay 0% of its total liabilities (CN¥221.51 Million) in one year. See Shandong Sinobioway Biomedicine Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Sinobioway Biomedicine Co Ltd Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Shandong Sinobioway Biomedicine Co Ltd across 18 annual periods. Also explore Shandong Sinobioway Biomedicine Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shandong Sinobioway Biomedicine Co Ltd (2007–2024)
Year-by-year debt coverage analysis for Shandong Sinobioway Biomedicine Co Ltd. For market capitalisation and broader financial context, see 002581 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.04x | CN¥-6.55 Million | CN¥173.61 Million | ▲ +83.1% |
| 2023 | -0.22x | CN¥-36.51 Million | CN¥163.41 Million | ▼ -59.7% |
| 2022 | -0.14x | CN¥-54.49 Million | CN¥389.46 Million | ▲ +12.8% |
| 2021 | -0.16x | CN¥-46.02 Million | CN¥286.76 Million | ▼ -320.5% |
| 2020 | 0.07x | CN¥18.51 Million | CN¥254.33 Million | ▲ +54.1% |
| 2019 | 0.05x | CN¥48.41 Million | CN¥1.03 Billion | ▼ -6.5% |
| 2018 | 0.05x | CN¥74.46 Million | CN¥1.47 Billion | ▼ -79.9% |
| 2017 | 0.25x | CN¥271.11 Million | CN¥1.08 Billion | ▼ -76.2% |
| 2016 | 1.06x | CN¥169.32 Million | CN¥160.16 Million | ▲ +108.7% |
| 2015 | 0.51x | CN¥137.73 Million | CN¥271.92 Million | ▼ -87.3% |
| 2014 | 3.99x | CN¥80.11 Million | CN¥20.08 Million | ▲ +70.3% |
| 2013 | 2.34x | CN¥83.13 Million | CN¥35.49 Million | ▼ -8.5% |
| 2012 | 2.56x | CN¥63.04 Million | CN¥24.62 Million | ▼ -38.4% |
| 2011 | 4.15x | CN¥74.43 Million | CN¥17.91 Million | ▲ +56.7% |
| 2010 | 2.65x | CN¥85.71 Million | CN¥32.34 Million | ▲ +72.8% |
| 2009 | 1.53x | CN¥54.06 Million | CN¥35.24 Million | ▼ -10.3% |
| 2008 | 1.71x | CN¥46.89 Million | CN¥27.41 Million | ▼ -20.8% |
| 2007 | 2.16x | CN¥25.07 Million | CN¥11.60 Million | — |